Cstl stock futures
WebThe consensus among . 3 Wall Street analysts covering (NASDAQ: CSTL) stock is to Strong Buy CSTL stock. Out of 3 analysts , 1 ( 33.33% ) are recommending CSTL as a Strong Buy, 2 ( 66.67% ) are recommending CSTL as a Buy, 0 ( 0% ) are recommending CSTL as a Hold, 0 ( 0% ) are recommending CSTL as a Sell, and 0 ( 0% ) are … Web102 rows · Apr 13, 2024 · Discover historical prices for CSTL stock on Yahoo Finance. View daily, weekly or monthly format back to when Castle Biosciences, Inc. stock was issued.
Cstl stock futures
Did you know?
WebCastle Biosciences Receives Accreditation from the College of American Pathologists for its Pittsburgh Clinical Laboratory Business Wire - Mon Nov 21, 6:00AM CST . Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the Accreditation Committee of the College of … WebDec 16, 2024 · Hedge funds were also right about betting on CSTL as the stock returned 20.3% since the end of Q3 (through 12/14) and outperformed the market. Hedge funds were rewarded for their relative bullishness.
WebN/A. 1y Target Est. 45.88. Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth …
WebCSTL Complete Castle Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebHere you can find premarket quotes for relevant stock market futures (e.g. Dow Jones Futures, Nasdaq Futures and S&P 500 Futures) and world markets indices, commodities and currencies.
WebHere you can find premarket quotes for relevant stock market futures (e.g. Dow Jones Futures, Nasdaq Futures and S&P 500 Futures) and world markets indices, …
WebCastle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. chubb benefits centerWebMar 12, 2024 · The stock price of Castle Biosciences (NASDAQ: CSTL), a skin cancer diagnostic company, has seen a large 24% drop over the last ten trading days, while it is down 14% over the last five trading ... chubb berguesWebMar 1, 2024 · February 28, 2024, 7:35 PM · 3 min read. Castle Biosciences, Inc. (CSTL) came out with a quarterly loss of $0.78 per share versus the Zacks Consensus Estimate of a loss of $0.91. This compares to ... desert triathlon 2021WebName. Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a ... desert treasure pyramid trapsWebEarnings estimates and surprises for Castle Biosciences Inc (CSTL) are an important tool used to evaluate the company's overall strength and value of the stock. desert triathlonWebAfter hours stock quotes coverage from CNN. View post-market trading including futures information for the S&P 500, Nasdaq Composite and Dow Jones Industrial Average. desert triathlon 2022WebSee Castle Biosciences, Inc. (CSTL) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. chubb bhubaneswar office